[ Price : $8.95]
FDA warns external defibrillator makers that device problems and recalls need to improve or the industry will face tougher premark...[ Price : $8.95]
Federal Register Direct final rule/proposed rule: FDA updates the language and clarifies the regulations in its regulations on new...[ Price : $8.95]
Federal Register Final rule: FDA changes its animal drug regulations to reflect a change of sponsor for sulfadiazine and pyrimetha...[ Price : $8.95]
FDA approves a Shire NDA for Vyvanse capsules for treating attention deficit hyperactivity disorder in adolescents ages 13 to 17.[ Price : $8.95]
FDA approves Eisai Inc.s Halaven, a synthetic form of a compound derived from a sea sponge, to treat patients with metastatic brea...[ Price : $8.95]
FDA Matters editor Steven Grossman predicts more intense oversight and investigation hearings on Capitol Hill after the Republican...[ Price : $8.95]
A month before it hears critics of its 2009 dental amalgam rule that the device is safe, FDA is confronted by two new studies cont...[ Price : $8.95]
FDA grants Sangart, Inc. orphan drug designation for MP4CO for use in treating acute sickling crises in patients with sickle cell ...